Professor Anthony S. WierzbickiDM DPhil FRCPath

Anthony has been a clinical consultant in metabolic medicine and chemical pathology at Guy’s & St Thomas' Hospital since 1995 and a Reader in Lipids and Cardiometabolic Disease at King’s College London since 2010.

He started as clinical lead for clinical biochemistry in 2008 and was appointed head of Blood Sciences in 2012.

He has been the Head of the Lipid Unit at Guy’s and St Thomas' Hospitals since 1995. In 1998 he was responsible for the discovery of the second locus for Adult Refsum Disease.

In 2007 he initiated a bariatric medical-surgical obesity service at Guy’s & St Thomas' Hospitals.

He has been a Member of the South London Cardiac Networks since 2005, is a Founder member of the Lipid and Cardiovascular Specialist Assay Services Group since 2006 and was Secretary and later became Chair of the Medical Committee of HEART-UK (UK Cholesterol Charity) 2003-9.

He is Chair of the Lipids & Cardiovascular Risk Assessment Guideline Group at NICE 2012-14 and a member of the Highly Specialist Technologies appraisal Committee at NICE (2013-).

Previously at NICE he was a clinical expert for technology appraisal TA 132 (ezetimibe; 2007-8); a guideline group member of Clinical Guideline 71 (familial hypercholesterolaemia (FH); 2007-9); Elucigene/LipoChip diagnostic appraisal 2 for genetic technology in FH (2011-12); and Technology Appraisal panel A 2009-2012. 

Anthony has an International reputation in lipids and cardiovascular disease prevention and is an international authority on adult single gene peroxisomal disorders. He is a Member of numerous national and international advisory groups on lipid metabolism and clinical application of lipid diagnostics and therapeutics.  

His qualifications include a DPhil in Calcium Channels, University of Oxford 1992, a DM in Clinical, biochemical and genetics aspects of Refsum Disease; University of Oxford 2004.

He is a Fellow of the Royal College of Pathologists, a Fellow of the National Association of Clinical Biochemistry (USA) and a Fellow of the American Heart Association and was appointed as a professor in April 2014.